[Reuters] – GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday. GSK …
Read more on this.
Abbott Laboratories (ABT), currently … [visit site to read more]
Similar Articles:- Company Update – AbbVie Inc. (NYSE:ABBV) – European drug trial secrecy case hit by delay
- Company Update – Google Inc. (NASDAQ:GOOG) – Paris court orders blocking of 16 video streaming sites
- Company Update: Microsoft Corporation (NYSE:MSFT) – Canada court allows Microsoft suit to proceed, says no on ADM